Skip to main content
Log in

Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma

  • Research Article
  • Published:
Tumor Biology

Abstract

Beclin 1, an important autophagy-related protein in human cells, is involved in autophagy, differentiation, anti-apoptosis, and cancer suppression, which is increased during periods of cell stress and extinguished during cell cycle. Human ovarian tumors display allelic loss of Beclin 1 with high frequency. To clarify Beclin 1's role in ovarian carcinogenesis and subsequent progression, its expression was examined by immunostaining on tissue microarrays containing ovarian normal tissue, benign and borderline tumors, and carcinomas. Beclin 1 mRNA and protein expression was examined in ovarian normal tissue, benign and borderline tumors, carcinoma tissue, and cell lines by reverse transcription polymerase chain reaction or Western blot, respectively. The results demonstrated that the higher Beclin 1 mRNA was observed in ovarian benign tumor than normal ovary and ovarian carcinoma (P < 0.05) and negatively correlated with the differentiation of ovarian carcinoma (P < 0.05). Beclin 1 protein expression was stronger in ovarian carcinoma than that in normal ovary and inversely related to the differentiation of ovarian carcinoma (P < 0.05) by Western blot. Immunohistochemically, Beclin 1 expression was statistically higher in ovarian borderline tumor and carcinoma than normal ovary and benign tumor (P < 0.05) and inversely linked to differentiation, lower ki-67 expression, and higher cumulative or relapse-free survival rate of ovarian carcinoma (P < 0.05). Cox proportional hazard model indicated that age and International Federation of Gynecology and Obstetrics staging (P < 0.05), but not pathological classification differentiation degree or Beclin 1 expression, were independent prognostic factors for overall and relapse-free ovarian carcinomas (P > 0.05). It was suggested that the aberrant Beclin 1 expression is closely linked to tumorigenesis and differentiation of ovarian carcinoma. Beclin 1 expression might be employed to indicate the worse prognosis of ovarian carcinomas, albeit not an independent factor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Liang XH, Jackson S, Seaman M, et al. Induction of autophagy and inhibition of tumorigenesis by Beclin 1. Nature. 1999;402:672–6.

    Article  CAS  PubMed  Google Scholar 

  2. Liang XH, Yu J, Brown K, Levine B. Beclin 1 contains a leucine-rich nuclear export signal that is required for its autophagy and tumor suppressor function. Cancer Res. 2001;61:3443–9.

    CAS  PubMed  Google Scholar 

  3. Kang R, Livesey KM, Zeh HJ, Loze MT, Tang D. HMGB1: a novel Beclin 1-binding protein active in autophagy. Autophagy. 2010;6:1209–11.

    Article  CAS  PubMed  Google Scholar 

  4. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011;18:571–80.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Li H, Wang P, Sun Q, et al. Following cytochrome c release, autophagy is inhibited during chemotherapy-induced apoptosis by caspase 8-mediated cleavage of Beclin 1. Cancer Res. 2011;71:3625–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Zhu Y, Zhao L, Liu L, et al. Beclin 1 cleavage by caspase-3 inactivates autophagy and promotes apoptosis. Protein Cell. 2010;1:468–77.

    Article  CAS  PubMed  Google Scholar 

  7. Wang ZH, Xu L, Duan ZL, Zeng LQ, Yan NH, Peng ZL. Beclin 1-mediated macroautophagy involves regulation of caspase-9 expression in cervical cancer HeLa cells. Gynecol Oncol. 2007;107:107–13.

    Article  CAS  PubMed  Google Scholar 

  8. John S, Nayvelt I, Hsu HC, et al. Regulation of estrogenic effects by Beclin 1 in breast cancer cells. Cancer Res. 2008;68:7855–63.

    Article  CAS  PubMed  Google Scholar 

  9. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A. 2003;100:15077–82.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  10. Qu X, Yu J, Bhagat G, et al. Promotion of tumorigenesis by heterozygous disruption of the Beclin 1 autophagy gene. J Clin Invest. 2003;112:1809–20.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Pickford F, Masliah E, Britschgi M, Lucin K, Narasimhan R, Jaeger PA, et al. The autophagy-related protein Beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J Clin Invest. 2008;118:2190–9.

    PubMed Central  CAS  PubMed  Google Scholar 

  12. Tannous P, Zhu H, Johnstone JL, et al. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc Natl Acad Sci U S A. 2008;105:9745–50.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Aita VM, Liang XH, Murty VV, et al. Cloning and genomic organization of Beclin 1, a candidate tumor suppressor gene on chromosome 17q21. Genomics. 1999;59:59–65.

    Article  CAS  PubMed  Google Scholar 

  14. Wang ZH, Peng ZL, Duan ZL, Liu H. Expression and clinical significance of autophagy gene Beclin 1 in cervical squamous cell carcinoma. Sichuan Da Xue Xue Bao Yi Xue Ban. 2006;37:860–3.

    CAS  PubMed  Google Scholar 

  15. Shi YH, Ding ZB, Zhou J, Qiu SJ, Fan J. Prognostic significance of Beclin 1-dependent apoptotic activity in hepatocellular carcinoma. Autophagy. 2009;5:380–2.

    Article  CAS  PubMed  Google Scholar 

  16. Duan ZL, Peng ZL, Wang ZH. Expression and involved signal transduction pathway of autophagy gene Beclin 1in epithelial ovarian cancer. Sichuan Da Xue Xue Bao Yi Xue Ban. 2007;38:239–42.

    CAS  PubMed  Google Scholar 

  17. Huang X, Bai HM, Chen L, Li B, Lu YC. Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci. 2010;17:1515–9.

    Article  CAS  PubMed  Google Scholar 

  18. Jiang ZF, Shao LJ, Wang WM, Yan XB, Liu RY. Decreased expression of Beclin-1 and LC3 in human lung cancer. Mol Biol Rep. 2012;39:259–67.

    Article  CAS  PubMed  Google Scholar 

  19. Ahn CH, Jeong EG, Lee JW, et al. Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. APMIS. 2007;115:1344–9.

    Article  PubMed  Google Scholar 

  20. Okura R, Nakamura M. Overexpression of autophagy-related beclin-1 in cutaneous squamous cell carcinoma with lymph-node metastasis. Eur J Dermatol. 2011;21:1002–3.

    PubMed  Google Scholar 

  21. Kim HS, Lee SH, Do SI, Lim SJ, Park YK, Kim YW. Clinicopathologic correlation of beclin-1 expression in pancreatic ductal adenocarcinoma. Pathol Res Pract. 2011;207:247–52.

    Article  CAS  PubMed  Google Scholar 

  22. Dong LW, Hou YJ, Tan YX, et al. Prognostic significance of Beclin 1 in intrahepatic cholangiocellular carcinoma. Autophagy. 2011;7:1222–9.

    Article  CAS  PubMed  Google Scholar 

  23. Song H, Xia SL, Liao C, et al. Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma. World J Gastroenterol. 2004;10:509–13.

    CAS  PubMed  Google Scholar 

  24. Piek JM, van Diest PJ, Verheijen RH. Ovarian carcinogenesis: an alternative hypothesis. Adv Exp Med Biol. 2008;622:79–87.

    Article  CAS  PubMed  Google Scholar 

  25. Bandera CA. Advances in the understanding of risk factors for ovarian cancer. J Reprod Med. 2005;50:399–406.

    PubMed  Google Scholar 

  26. Zheng H, Tsuneyama K, Cheng C, et al. An immunohistochemical study of p53 and Ki-67 in gastrointestinal adenoma and adenocarcinoma using tissue microarray. Anticancer Res. 2006;26:2353–60.

    CAS  PubMed  Google Scholar 

  27. Karam AK, Karlan BY. Ovarian cancer: the duplicity of CA125 measurement. Nat Rev Clin Oncol. 2010;7:335–9.

    Article  CAS  PubMed  Google Scholar 

  28. Li W, Murai Y, Okada E, et al. Modified and simplified western blotting protocol: use of intermittent microwave irradiation (IMWI) and 5% skim milk to improve binding specificity. Pathol Int. 2002;52:234–8.

    Article  PubMed  Google Scholar 

  29. Kumada T, Tsuneyama K, Hatta H, Ishizawa S, Takano Y. Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital. Mod Pathol. 2004;17:1141–9.

    Article  PubMed  Google Scholar 

  30. Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 2007;17:839–49.

    Article  CAS  PubMed  Google Scholar 

  31. Chen YB, Hou JH, Feng XY, et al. Decreased expression of Beclin 1 correlates with a metastatic phenotypic feature and adverse prognosis of gastric carcinomas. J Surg Oncol. 2012;105:542–7.

    Article  CAS  PubMed  Google Scholar 

  32. Wang ZH, Xu L, Wang Y, Cao MQ, Li L, Bai T. Clinicopathologic correlations between human papillomavirus 16 infection and Beclin 1 expression in human cervical cancer. Int J Gynecol Pathol. 2011;30:400–6.

    Article  PubMed  Google Scholar 

  33. Chen Y, Lu Y, Lu C, Zhang L. Beclin-1 expression is a predictor of clinical outcome in patients with esophageal squamous cell carcinoma and correlated to hypoxia- inducible factor (HIF)-1alpha expression. Pathol Oncol Res. 2009;15:487–93.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Pirtoli L, Cevenini G, Tini P, et al. The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy. 2009;5:930–6.

    Article  PubMed  Google Scholar 

  35. Wan XB, Fan XJ, Chen MY, et al. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicting poor prognosis of nasopharyngeal carcinoma. Autophagy. 2010;6:395–404.

    Article  CAS  PubMed  Google Scholar 

  36. Koukourakis MI, Giatromanolaki A, Sivridis E, Pitiakoudis M, Gatter KC, Harris AL. Beclin 1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer. 2010;103:1209–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Huang JJ, Li HR, Huang Y, et al. Beclin 1 expression: a predictor of prognosis in patients with extranodal natural killer T-cell lymphoma, nasal type. Autophagy. 2010;6:777–83.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by the Shenyang Outstanding Talent Foundation of China, Shenyang Science and Technology Grant (F11-264-1-10; F12-277-1-01), Project Supported by Scientific Research Fund of Liaoning Provincial Education Department (L2010633), Liaoning Science and Technology Grant (2009225008-11), Natural Scientific Foundation of China (nos. 81172371 and 81202049), and Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports and Technology of Japan (23659958).

Conflicts of interest

None

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hua-chuan Zheng.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhao, Y., Chen, S., Gou, Wf. et al. Aberrant Beclin 1 expression is closely linked to carcinogenesis, differentiation, progression, and prognosis of ovarian epithelial carcinoma. Tumor Biol. 35, 1955–1964 (2014). https://doi.org/10.1007/s13277-013-1261-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-013-1261-6

Keywords

Navigation